Table 2.
Clinical Characteristics of the Patients with Cancer and Tumor Characteristics
| N | Gender (F/M) | Positive Family History (Y/N) | Age at Diagnosis of HT (Y) | Age at Diagnosis of the Nodules (Y) | Age at Diagnosis of the Cancer (Y) | Clinical Data at Diagnosis of Cancer |
Biochemical Data at Diagnosis | Ultrasound Data |
FNAB | Histology | TNM Classification | Additional Pathologies | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cervical Adenopathy (Y/N) | Signs of Local Compression (Y/N) | A: Euthyroidism; B: Subclinical hypothyroidism; C: Hypothyroidism; | Thyroid Nodularity: U: Uninodular; M: Multinodular | Largest Diameter of the Nodules at Diagnosis (cm) | Growth of the Nodule | ||||||||||
| A: None | |||||||||||||||
| B: While in Therapy; | |||||||||||||||
| C: Without Therapy | |||||||||||||||
| D: Appearance of the Nodule During Therapy | |||||||||||||||
| 1 | F | N | 14 | 14 | 14 | Y | N | A | U | 1.1 | A | TIR 5 | PTC | pT1bN1a M0 | Von Willebrand disease |
| 2 | F | N | 12.2 | 16.8 | 16.8 | Y | N | B | U | 1.3 | D | TIR 3b | PTC | pT1bN1a M0 | |
| 3 | F | Y | 12.5 | 12.5 | 12.5 | Y | Y | A | M | 2.1 | A | TIR 4 | PTCfollicular variant | pT3N1b M0 | |
| 4 | M | N | 12.8 | 12.8 | 13.9 | Y | N | C | U | 2.2 | A | TIR 4 | PTCfollicular variant | pT1bN1a M0 | |
| 5 | M | N | 12 | 13.9 | 16.1 | Y | N | B | M | 1.5 | D | TIR 4 | PTC | pT3aN1a M0 | Addison disease |
| 6 | F | Y | 12,3 | 12,3 | 13,4 | Y | Y | A | M | 3.0 | A | TIR 5 | PTCfollicular variant | pT3aN1a M0 | |
| 7 | M | N | 7.9 | 7.9 | 7,9 | Y | Y | A | U | 1.5 | A | TIR 5 | PTC | pT3aN1a M0 | |
| 8 | F | Y | 10.6 | 10.6 | 12.6 | Y | N | B | U | 1.0 | C | TIR 4 | PTCfollicular variant | pT2N1a M0 | |
| 9 | M | N | 11 | 11 | 11,6 | Y | N | A | U | 0,8 | D | TIR 5 | PTC | pT3N1aM0 | |
| 10 | F | Y | 11.7 | 11.7 | 13.6 | Y | N | A | M | 2.4 | B | TIR 3b | PTC | pT2N1a M0 | |